FARMINGDALE, N.Y., Jan. 12 /PRNewswire-FirstCall/ -- Misonix, Inc. , a developer of minimally invasive ultrasonic medical device technology, which in Europe is used for the ablation of tumors and worldwide for other acute health conditions, has entered into a new, three year distribution agreement with Neuromed Chile, S.A., based in Santiago, Chile, for the distribution of the SonaStar(TM) Ultrasonic Surgical Aspirator and the BoneScalpel(TM) Ultrasonic Bone Cutter. The agreement provides Neuromed with the exclusive rights to sell in Chile and includes minimum purchase requirements. The addition of Neuromed marks our 7th distributor in Latin America and our 29th distributor for the export market.
The SonaStar is used by Neuro and General Surgeons for quick and efficient removal of both hard and soft tumors while sparing most vessels. In addition, OsteoSculpt(TM) bone sculpting technology can be employed with the SonaStar to safely remove osseous structures, thus providing access to the surgical site.
"Misonix is pleased to add Neuromed Chile to our family of Latin American specialty distributors, a geographic area that is receiving a focused effort from our Sales and Marketing team," said Michael A. McManus, Jr., President and Chief Executive Officer of Misonix. "We are particularly pleased that they will be distributing two of our key products through their well established surgical products organization."
Misonix, Inc. designs, develops, manufactures and markets therapeutic ultrasonic medical devices and laboratory equipment. Misonix's therapeutic ultrasonic platform is the basis for several innovative medical technologies. Addressing a combined market estimated to be in excess of $3 billion annually; Misonix's proprietary ultrasonic medical devices are used for wound debridement, cosmetic surgery, neurosurgery, laparoscopic surgery, and other surgical and medical applications. Additional information is available on the Company's Web site at www.misonix.com.
CONTACT: Misonix Contact: Richard Zaremba, +1-631-694-9555,
invest@misonix.com; or Investor Relations Contact: Kevin McGrath/Cameron
Associates, Inc., +1-212-245-4577, Kevin@cameronassoc.com
Web site: http://www.misonix.com/
